株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

小児科関連の各種提携契約:契約条件・合意内容

Global Pediatrics Partnering 2010-2016: Deal trends, players and financials

発行 Current Partnering, a division of Wildwood Ventures Limited 商品コード 250964
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
小児科関連の各種提携契約:契約条件・合意内容 Global Pediatrics Partnering 2010-2016: Deal trends, players and financials
出版日: 2016年09月01日 ページ情報: 英文
概要

当レポートでは、小児科関連の各種提携契約について調査分析し、近年における各種契約の動向、大規模契約および大手医薬品事業者による契約の概要、契約区分・開発ステージ・技術区分・適応症区分別のディレクトリなどをまとめ、概略下記の構成でお届けいたします。

エグゼクティブサマリー

第1章 イントロダクション

第2章 心血管の契約動向

  • イントロダクション
  • 長期契約
  • 大手製薬企業における小児科の契約活動
  • 小児科の提携に消極的な大手製薬企業
  • 契約タイプ別
  • 産業分野別
  • 開発段階別
  • 技術タイプ別
  • 症状別
  • 平均契約期間

第3章 主要契約

  • イントロダクション
  • 主要契約:契約額別
  • 大手製薬関連の主要契約

第4章 大手製薬企業による小児科の関連の各種契約

  • イントロダクション
  • 大手企業による提携取引の利用方法
  • 企業プロファイル

第5章 小児科の提携契約ディレクトリ

  • イントロダクション
  • 契約タイプ別
  • 開発段階別
  • 技術タイプ別

第6章 小児科の契約:症状別

  • イントロダクション
  • 契約:治療指標別
    • 麻酔
    • 心血管
    • 中枢神経系
    • 化粧品
    • 歯科
    • 皮膚科
    • 胃腸
    • 遺伝性疾患
    • 泌尿生殖器
    • 婦人科
    • 血液学
    • ホスピタルケア
    • 免疫学
    • 感染症
    • 代謝
    • 筋骨格系
    • 産科
    • 眼科
    • 小児科
    • 精神科
    • 呼吸器科

第7章 提携リソースセンター

  • オンライン提携
  • 提携イベント
  • 参考資料

付録

Wildwood Venturesについて

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: CP2225

‘Global Pediatrics Partnering 2010-2016: Deal trends, players and financials’ provides comprehensive understanding and unprecedented access to the pediatrics partnering deals and agreements entered into by the worlds leading healthcare companies

‘Global Pediatrics Partnering 2010 to 2016’ provides the full collection of Pediatrics disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

  • Trends in Pediatrics partnering deals
  • Financial deal terms for headline, upfront and royalty by stage of development
  • Pediatrics partnering agreement structure
  • Pediatrics partnering contract documents
  • Top Pediatrics deals by value
  • Most active Pediatrics dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Pediatrics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Pediatrics deals.

The report presents financial deal terms values for Pediatrics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Pediatrics dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Pediatrics dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Pediatrics deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Pediatrics dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Pediatrics deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Pediatrics partnering deals by specific Pediatrics target announced since 2010. The chapter is organized by specific Pediatrics therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Pediatrics partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Pediatrics partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Pediatrics technologies and products.

Report scope

‘Global Pediatrics Partnering 2010 to 2016 ’is intended to provide the reader with an in-depth understanding and access to Pediatrics trends and structure of deals entered into by leading companies worldwide.

‘Global Pediatrics Partnering 2010 to 2016’ includes:

  • Trends in Pediatrics dealmaking in the biopharma industry since 2010
  • Analysis of Pediatrics deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Pediatrics deal contract documents
  • Comprehensive access to over 3500 Pediatrics deal records
  • The leading Pediatrics deals by value since 2010
  • Most active Pediatrics dealmakers since 2010

In ‘Global Pediatrics Partnering 2010 to 2016’, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The ‘Global Pediatrics Partnering 2010-2016’ report provides comprehensive access to available deals and contract documents for over 200 pediatrics deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

‘Global Pediatrics Partnering 2010 to 2016’ provides the reader with the following key benefits:

  • In-depth understanding of Pediatrics deal trends since 2010
  • Access Pediatrics deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between Pediatrics partner companies
  • Comprehensive access to over 750 links to actual Pediatrics deals entered into by the world's biopharma companies
  • Indepth review of Pediatrics deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner Pediatrics opportunities
  • Uncover companies actively partnering Pediatrics opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Pediatrics dealmaking

  • 2.1. Introduction
  • 2.2. Pediatrics partnering over the years
  • 2.3. Pediatrics partnering by deal type
  • 2.4. Pediatrics partnering by industry sector
  • 2.5. Pediatrics partnering by stage of development
  • 2.6. Pediatrics partnering by technology type
  • 2.7. Pediatrics partnering by therapeutic indication

Chapter 3 -Financial deal terms for Pediatrics partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Pediatrics partnering
  • 3.3. Pediatrics partnering headline values
  • 3.4. Pediatrics deal upfront payments
  • 3.5. Pediatrics deal milestone payments
  • 3.6. Pediatrics royalty rates

Chapter 4 - Leading Pediatrics deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Pediatrics partnering
  • 4.3. List of most active dealmakers in Pediatrics
  • 4.4. Top Pediatrics deals by value

Chapter 5 - Pediatrics contract document directory

  • 5.1. Introduction
  • 5.2. Pediatrics partnering deals where contract document available

Chapter 6 - Pediatrics dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Pediatrics therapeutic target

Appendices

  • Appendix 1 - Directory of Pediatrics deals by company A-Z 2010 to 2016
  • Appendix 2 - Directory of Pediatrics deals by deal type 2010 to 2016
  • Appendix 3 - Directory of Pediatrics deals by stage of development 2010 to 2016
  • Appendix 4 - Directory of Pediatrics deals by technology type 2010 to 2016
  • Further reading on dealmaking
  • Deal type definitions

About Wildwood Ventures

  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering

Table of figures

  • Figure 1: Pediatrics partnering since 2010
  • Figure 2: Pediatrics partnering by deal type since 2010
  • Figure 3: Pediatrics partnering by industry sector since 2010
  • Figure 4: Pediatrics partnering by stage of development since 2010
  • Figure 5: Pediatrics partnering by technology type since 2010
  • Figure 6: Pediatrics partnering by indication since 2010
  • Figure 7: Pediatrics deals with a headline value
  • Figure 8: Pediatrics deals with upfront payment values
  • Figure 9: Pediatrics deals with milestone payment
  • Figure 10: Pediatrics deals with royalty rates
  • Figure 11: Active Pediatrics dealmaking activity- 2010 to 2016
  • Figure 12: Top Pediatrics deals by value since 2010
Back to Top